As questions continue to surface about the potential link between prenatal acetaminophen use and autism spectrum disorder, pharmacists must be prepared to address patient concerns with confidence and clarity. This episode explores the current body of evidence, public health messaging, and practical strategies for counseling during pregnancy. Tune in to strengthen your knowledge and support safe, evidence-informed guidance for your patients.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
John Swegle, PharmD
Clinical Associate Professor
University of Iowa College of Pharmacy

Joshua Davis Kinsey and John Swegle have no relevant financial relationships with ineligible companies to disclose.
 
CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize current evidence regarding the association between prenatal acetaminophen exposure and autism spectrum disorder.
2. Identify patient counseling considerations for the safe use of acetaminophen during pregnancy.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-310-H01-P
Initial release date: 10/13/2025
Expiration date: 10/13/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram